I totally agree.
Every poster here has had the opportunity to buy AHZ at these prices.
I think a few investors on this forum are very anxious.
All new medical research is very complicated and potentially has great financial risk to investors.
Alternatively great risk can come with great reward to investors.
AHZ is a great business that has solid products building over time and also has a component of high risk medical research.
It is great to have a healthy forum.
It is much easier these days to trade in and trade out.
Investors no longer have to put up with companies they are not happy with and can sell in an instant.
Merry Christmas to all.
MB
Sabby Management Fund, page-48
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.15 |
Change
-0.250(2.40%) |
Mkt cap ! $214.5M | |||
| Open | High | Low | Value | Volume |
| $10.57 | $10.59 | $9.90 | $181.3K | 17.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 720 | $10.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.35 | 3407 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |